The use of live attenuated influenza vaccine (LAIV) in healthcare personnel (HCP): Guidance from the society for healthcare epidemiology of America (SHEA)

Infection Control and Hospital Epidemiology

Volumn 33, Issue 10, 2012, Pages 981-983

  Talbot, Thomas R ^a   Babcock, Hilary ^b   Cotton, Deborah ^c,d   Maragakis, Lisa L ^e   Poland, Gregory A ^f   Septimus, Edward J ^g,h   Tapper, Michael L ⁱ   Weber, David J ^j  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Mayo Clinic   (United States)

^g HOSPITAL CORPORATION OF AMERICA   (United States)

^h TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

ⁱ NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION CONTROL; INFLUENZA; INFLUENZA VACCINATION; MEDICAL SOCIETY; PATIENT SAFETY; PRACTICE GUIDELINE; VIRUS SHEDDING; VIRUS TRANSMISSION;

HEALTH PERSONNEL; HUMANS; INFECTION CONTROL; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PRACTICE GUIDELINES AS TOPIC; UNITED STATES; VACCINES, ATTENUATED; VIRUS SHEDDING;

EID: 84866150437     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/667772     Document Type: Article

References (20)

1. Centers for Disease Control and Prevention. Influenza vacci nation coverage among health-care personnel: United States, 2010-11 influenza season. MMWR Morb Mortal Wkly Rep 2011; 60(32):1073-1077.
2. Centers for Disease Control and Prevention. Licensure of a highdose inactivated influenza vaccine for persons aged ≥65 years (Fluzone High-Dose) and guidance for use: United States, 2010. MMWR Morb Mortal Wkly Rep 2010;59(16):485-486.
3. Fluzone Intradermal (influenza virus vaccine): facts at a glance. http://multivu.prnewswire.com/mnr/sanofipasteur/49833/docs/49833-Fluzone_ID_Fact_Sheet.pdf. Accessed May 22, 2012.
4. Greenberg DP, Robertson C, Talbot HK, Decker MD. Safety and immunogenicity of a quadrivalent inactivated influenza vaccine (QIV) containing two A and two B strains among persons ≥65 years of age. Paper presented at: 49th Annual Meeting of the Infectious Diseases Society of America, 21 October 2011; Boston,MA. https://idsa.confex.com/idsa/2011/webprogram/Paper31024.html. Accessed May 22, 2012.
5. Gregersen JP, Schmitt HJ, Trusheim H, Broker M. Safety of MDCK cell culture-based influenza vaccines. Future Microbiol 2011;6(2):143-152.
6. Monto AS, Ohmit SE, Petrie JG, et al. Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med 2009;361(13):1260-1267.
7. Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007;356(7):685-696.
8. Block SL, Yogev R, Hayden FG, Ambrose CS, Zeng W, Walker RE. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age. Vaccine 2008;26(38): 4940-4946.
9. Hammitt LL, Bartlett JP, Li S, et al. Kinetics of viral shedding and immune responses in adults following administration of cold-adapted influenza vaccine. Vaccine 2009;27(52):7359-7366.
10. Tosh PK, Boyce TG, Poland GA. Flu myths: dispelling the myths associated with live attenuated influenza vaccine. Mayo Clin Proc 2008;83(1):77-84.
11. Fiore AE, Shay DK, Broder K, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009;58(RR-8):1-52.
12. Vesikari T, Fleming DM, Aristegui JF, et al. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care. Pediatrics 2006;118(6):2298-2312.
13. Pearson ML, Bridges CB, Harper SA. Influenza vaccination of health-care personnel: recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55(RR-2):1-16.
14. Centers for Disease Control and Prevention. Additional information about vaccination of specific populations: persons who live with or care for persons at higher risk for influenzarelated complications. http://www.cdc.gov/flu/professionals/acip/specificpopulations.htm. Accessed August 24, 2012.
15. Levin MJ, Song LY, Fenton T, et al. Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children. Vaccine 2008;26(33):4210-4217.
16. King JC Jr, Treanor J, Fast PE, et al. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non- HIV-infected adults. J Infect Dis 2000;181(2):725-728.
17. Gorse GJ, O'Connor TZ, Young SL, et al. Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study. Vaccine 2003;21(17/18):2133-2144.
18. Carr S, Allison KJ, Van De Velde LA, et al. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. J Infect Dis 204(10):1475-1482.
19. Jackson LA, Holmes SJ, Mendelman PM, Huggins L, Cho I, Rhorer J. Safety of a trivalent live attenuated intranasal influenza vaccine, FluMist, administered in addition to parenteral trivalent inactivated influenza vaccine to seniors with chronic medical conditions. Vaccine 1999;17(15/16):1905-1909.
20. Hernandez L. Hospitals shun H1N1 FluMist vaccine, wait for injections. October 6, 2009. http://www.thedenverchannel.com/news/21212055/detail.html. Accessed June 6, 2012.